Australia's Bioxyne rises on acquisition of health and wellness firm

BLS Pharmaceuticals

19/12/2022 24:40

** Shares of Bioxyne Ltd  BXN.AX  rise as much as 3.9% to
A$0.027, their highest since Nov 3
    ** The health and wellness products firm enters into binding
term-sheet to acquire Breathe Life Sciences Pty Ltd, a health
and wellness co  urn:newsml:reuters.com:*:nASX4s24Kr 
    ** Says consideration for acquisition is 1.23 bln shares in
BXN at issue price of A$0.03 per share 
    ** Says acquisition will expand Bioxyne's product range 
    ** Co shares down 10.3% YTD, as of last close 
 (Reporting by John Biju in Bengaluru)
 ((John.Biju@thomsonreuters.com;))